Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06605014

Somatic Dysfunction in Patients With Acute Cerebrovascular Disease

The goals of this observational study are to test the reliability of a new, standardized physical examination method to identify motion problems within joints or groups of joints among adult asymptomatic volunteers and in patients hospitalized with stroke or stroke-like episodes (e.g., transient ischemic attack, TIA). The main questions this investigation aims to answer are:

* Can different, independent providers reliability quantify motion pattern problems using a systematic approach called, The Functional Pathology of the Musculoskeletal System (FPMSS) model? * Are there differences in joint(s) motion patterns among asymptomatic volunteers, patients with TIA (people with brain disease without new neurologic disability), and recent ischemic stroke (patients with new stroke-related-disability, e.g., paralysis)? * Is there an association between joint(s) motion impairment severity and stroke survivor outcomes?

Participants (asymptomatic and those with stroke) will undergo a set of repeated paired, musculoskeletal physical exams by independent providers blinded to each other's assessments and patient information. Researchers will compare the severity, location, and quantity of joint(s) motion impairment between these three groups with the physical examination methodology (FPMSS). Clinical information (e.g., test results, diagnoses, brain imaging, medical history) will be collected from patients admitted for TIA and stroke. Enrolled participants with recent stroke will complete a survey three months after hospitalization to determine their self-perceived quality-of-life.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Stroke, Acute Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Health-Related Quality-of-Life Nervous System Diseases Osteopathic Manipulation Reproducibility of Results Stroke TIA Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of California Davis Medical Center

Sacramento, California, 95817, United States

Location status: Recruiting

Location contact

Alan Yee, D.O.

CONTACT

Alan Yee, D.O.

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults ≥18 years

Admission diagnosis:

  • ischemic stroke OR
  • transient ischemic attack (TIA). A prior history of TIA but without stroke may be enrolled.
  • Neurologic stability or lack of significant deterioration (i.e. ∆ NIHSS<4) for at least 24 hours (defined by clinical documentation and/or communication with provider team(s)) in stroke subjects
  • Able to sit upright, lie supine, and when able lateral recumbent left/right positions with assist independently or with minimal person assist
  • Anticipated length of stay greater > or = 2 days for ischemic stroke. TIA patients average length of stay is < 2 days, and can be enrolled in the study.

Exclusion criteria

  • Acute skeletal fracture or known dislocation; history of pathologic (osteoporotic or neoplastic) skeletal fracture of thoracic cage, hip/pelvis/sacrum, or vertebral column
  • Prior history of ICH, ischemic stroke, confirmed by imaging and/or clinical evaluation. Patients with imaging showing "chronic stroke" who have never received a diagnosis of stroke and/or have not been previously symptomatic may still be enrolled, based on the Investigator's clinical judgement.
  • Spinal column support brace (e.g. cervical collar)
  • Anticipated neurosurgical intervention during hospitalization: decompressive hemicraniectomy, hematoma evacuation (defined by clinical documentation and/or communication with provider team(s))
  • Current endotracheal intubation (*note: extubated patients can be evaluated for eligibility)
  • History of spinal cord injury with residual neuromuscular or sensory disability
  • History of recent trauma within the past 30 days
  • Known ligament, musculotendinous, or bone lesion
  • Clinical condition that would interfere with execution of movement or palpatory diagnostic testing, e.g. chronic pain
  • History of spinal surgery

Treatment and study plan

Primary outcomes

  1. Examiner Rater-Reliability

    Time frame: 3 to 14 days

    Test intra- and inter-rater reliability in identifying osteopathic somatic dysfunction (joint(s) motion impairment) among asymptomatic volunteers, patients with TIA, and recently admitted patients with stroke.

  2. Functional Pathology of the Musculoskeletal System

    Time frame: 3-14 days

    A total of 80 specific musculoskeletal examination tests are performed assessing the amount of available motion in the spine, upper extremities, lower extremities, and pelvis. Navigational Motions (i.e., whole upper limb motion at shoulder) are scored on a scale of 1-4 with one representing the least loss of motion and 4 representing the most and Component Motions (i.e., motion of foot at ankle) scored on a scale of 0-3 with 0 representing "normal motion" and 3 representing "no motion".

  3. National Institutes of Health Neuro-Quality of Life (QoL) survey

    Time frame: 90 days

    Quantify self-reported health-related quality-of-life (QoL) 90 days after ischemic stroke. Patient response domain scores have a normative distribution and are compared against general population means (50, with a standard deviation of 10; range 10-90). Interpreting value responses above or below means are based on the specific questions - i.e., higher scores do not uniformly reflect improvement while lower scores do not necessarily reflect poorer status. Patient will receive a digitally distributed survey inquiring about QoL domains surrounding mobility, satisfaction with and ability to participate in social roles, mood, fatigue, anxiety, cognition.

Study contacts

Contact information is provided by the study sponsor or research team.

Alan Yee, D.O.

CONTACT

[email protected]

916-734-3588

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Collaborators

  • American Osteopathic Association

Registry information

Official study title

Characterization of Somatic Dysfunction in Patients With Acute Cerebrovascular Disease

Acronym: SOMADC-AC

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Sep 20, 2024
Registry last updated
Sep 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.